Study of H1710 for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug called H1710 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if H1710 is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an advanced solid tumor that has not responded to standard treatments, or you cannot take standard treatments.
- Your tumor can be measured or evaluated on scans.
- You are able to care for yourself (ECOG score 0 or 1).
- Your organs and bone marrow are working well enough, as shown by blood tests.
- You are not at high risk for bleeding or have active bleeding issues.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new drug (HC010) for people with advanced solid tumors that have not responded to standard treatments. It aims to see if the drug is safe, how it works in the body, and whether it can shrink tumors.
This study tests a new drug called HC006 for advanced solid tumors that no longer respond to standard treatments. It aims to find a safe dose and see if it helps shrink tumors.
This Phase 1 study tests SB17170 in people with solid tumors that have spread or grown despite standard treatments. It looks for safety and early signs of how well the drug might work when other options have failed.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
This trial tests a new drug called HDM2017 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects tumors.
This trial tests a new drug called HRS-6719 for people with advanced or metastatic solid tumors that have progressed after standard treatments or for which no standard treatment exists. The goal is to see if the drug is safe and effective.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.